Filing Details
- Accession Number:
- 0001567619-22-003272
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-02-10 17:46:22
- Reporting Period:
- 2022-02-08
- Accepted Time:
- 2022-02-10 17:46:22
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1770787 | 10X Genomics Inc. | TXG | Laboratory Analytical Instruments (3826) | 455614458 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1786720 | Serge Saxonov | C/O 10X Genomics, Inc. 6230 Stoneridge Mall Road Pleasanton CA 94588 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Acquisiton | 2022-02-08 | 3,038 | $11.48 | 925,293 | No | 4 | M | Direct | |
Class A Common Stock | Disposition | 2022-02-08 | 900 | $88.17 | 924,393 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2022-02-08 | 4,200 | $89.19 | 920,193 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2022-02-08 | 4,503 | $90.30 | 915,690 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2022-02-08 | 2,397 | $91.04 | 913,293 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Class A Common Stock | Stock Option (right to buy) | Disposition | 2022-02-08 | 3,038 | $0.00 | 3,038 | $11.48 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
42,521 | 2029-05-10 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Class A Common Stock | 4,138 | Indirect | See footnote |
Class A Common Stock | 89,960 | Indirect | See footnote |
Footnotes
- The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
- This transaction was executed in multiple trades at prices ranging from $87.64 to $88.61. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $88.66 to $89.65. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $89.76 to $90.73. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- This transaction was executed in multiple trades at prices ranging from $90.765 to $91.41. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee.
- The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.
- This option, originally for 145,786 shares, of which 103,265 have been exercised, vested as to 1/48th of the shares on May 1, 2019, and 1/48th of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.